Wed, June 15, 2011
Tue, June 14, 2011
[ Tue, Jun 14th 2011 ] - Market Wire
Bond Labs Reports May Results
Mon, June 13, 2011
Fri, June 10, 2011
Thu, June 9, 2011
Wed, June 8, 2011
Tue, June 7, 2011
Mon, June 6, 2011
Sat, June 4, 2011
Fri, June 3, 2011
Thu, June 2, 2011
Wed, June 1, 2011
Tue, May 31, 2011
Mon, May 30, 2011
Fri, May 27, 2011
Thu, May 26, 2011
Wed, May 25, 2011
Tue, May 24, 2011
Mon, May 23, 2011
Sun, May 22, 2011
Fri, May 20, 2011
Thu, May 19, 2011
Wed, May 18, 2011
Tue, May 17, 2011
Mon, May 16, 2011

Salix Pharmaceuticals to Present at Three Investment Conferences in June


//health-fitness.news-articles.net/content/2011/ .. ent-at-three-investment-conferences-in-june.html
Published in Health and Fitness on Monday, May 30th 2011 at 5:10 GMT by Market Wire   Print publication without navigation


RALEIGH, N.C.--([ BUSINESS WIRE ])--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company will present at three health care investment conferences during June 2011. Information of these conferences is provided below:

Jefferies 2011 Global Healthcare Conference
New York, NY Monday, June 6, 2011 11:00 a.m. ET

Goldman Sachs 32nd Annual Global Healthcare Conference

Los Angeles, CA Wednesday, June 8, 2011 1:40 p.m. ET

2011 Wells Fargo Securities Healthcare Conference

Boston, MA Wednesday, June, 22 1:30 p.m. ET

Interested parties can access a live audio web cast of these presentations at [ http://www.salix.com ]. A replay of the presentations will be available at the same location.

Salix Pharmaceuticals, Ltd., headquartered in Raleigh, North Carolina, develops and markets prescription pharmaceutical products for the treatment of gastrointestinal diseases. Salixa™s strategy is to in-license late-stage or marketed proprietary therapeutic drugs, complete any required development and regulatory submission of these products, and market them through the Companya™s gastroenterology specialty sales and marketing team.

Salix trades on the NASDAQ Global Select Market under the ticker symbol aSLXPa.

For more information, please visit our Website at [ www.salix.com ] or contact the Company at 919-862-1000. Follow us on Twitter (@SalixPharma) and Facebook ([ www.facebook.com/SalixPharma ]). Information on our web site is not incorporated in our SEC filings.


Publication Contributing Sources